[Hypnotherapy and cognitive-behavioral therapy for depression - Results from the three and a half year follow-up of a randomized controlled non-inferiority study].

Pub Date : 2023-12-01 Epub Date: 2023-07-24 DOI:10.1055/a-2117-7188
Kristina Fuhr, Victoria Maren Beier, Christoph Meisner, Anil Batra
{"title":"[Hypnotherapy and cognitive-behavioral therapy for depression - Results from the three and a half year follow-up of a randomized controlled non-inferiority study].","authors":"Kristina Fuhr, Victoria Maren Beier, Christoph Meisner, Anil Batra","doi":"10.1055/a-2117-7188","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The scientific approval of hypnotherapy for certain mental disorders is still not confirmed. In a randomized-controlled study comparing the efficacy of hypnotherapy (HT) with cognitive behavioral therapy (CBT) for mild to moderate depressive episodes, a non-inferiority of HT compared to CBT could be found. The aim of this study was to examine depressive symptomatology in the long-term course three and a half years after end of the treatment.</p><p><strong>Methods: </strong>A total of 152 randomized patients received outpatient individual psychotherapy with 16 to 20 sessions over a period of six months. All were invited to participate in a follow-up three and a half years after the end of treatment where depressive symptoms were assessed via self- and clinician-ratings. In the per-protocol (PP) analysis, only those with available data were included, but a comparison of characteristics was made with individuals without participation in the follow-up survey. An additional intention-to-treat (ITT) analysis was conducted with multiple imputed data for missing data.</p><p><strong>Results: </strong>A total of 71 subjects (46.7%) participated in the follow-up. The noninferiority in the percentage symptom reduction assessed with the clinician-rating of HT compared with CBT was confirmed in the PP and the ITT sample. The symptom improvement in self- and clinician-rating by the end of therapy persisted during the follow-up. Response rates and remission rates for both self- and clinician-ratings are reported.</p><p><strong>Conclusion: </strong>In this study, indications were found that HT was noninferior to CBT in the treatment of depression, even in the long term. Further studies should examine the efficacy of HT in larger multicenter samples and identify predictors of individual treatment success.</p>","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1055/a-2117-7188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/7/24 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: The scientific approval of hypnotherapy for certain mental disorders is still not confirmed. In a randomized-controlled study comparing the efficacy of hypnotherapy (HT) with cognitive behavioral therapy (CBT) for mild to moderate depressive episodes, a non-inferiority of HT compared to CBT could be found. The aim of this study was to examine depressive symptomatology in the long-term course three and a half years after end of the treatment.

Methods: A total of 152 randomized patients received outpatient individual psychotherapy with 16 to 20 sessions over a period of six months. All were invited to participate in a follow-up three and a half years after the end of treatment where depressive symptoms were assessed via self- and clinician-ratings. In the per-protocol (PP) analysis, only those with available data were included, but a comparison of characteristics was made with individuals without participation in the follow-up survey. An additional intention-to-treat (ITT) analysis was conducted with multiple imputed data for missing data.

Results: A total of 71 subjects (46.7%) participated in the follow-up. The noninferiority in the percentage symptom reduction assessed with the clinician-rating of HT compared with CBT was confirmed in the PP and the ITT sample. The symptom improvement in self- and clinician-rating by the end of therapy persisted during the follow-up. Response rates and remission rates for both self- and clinician-ratings are reported.

Conclusion: In this study, indications were found that HT was noninferior to CBT in the treatment of depression, even in the long term. Further studies should examine the efficacy of HT in larger multicenter samples and identify predictors of individual treatment success.

分享
查看原文
[催眠疗法和认知行为疗法治疗抑郁症-来自一项随机对照非劣效性研究的三年半随访结果]。
目的:催眠治疗某些精神障碍的科学认可仍未得到证实。在一项比较催眠疗法(HT)与认知行为疗法(CBT)治疗轻至中度抑郁发作疗效的随机对照研究中,可以发现HT与CBT相比具有非劣效性。这项研究的目的是在治疗结束后三年半的长期过程中检查抑郁症状。方法:共152例随机患者接受门诊个体心理治疗,疗程为16 ~ 20次,为期6个月。所有人都被邀请参加治疗结束后三年半的随访,通过自我和临床评分来评估抑郁症状。在按方案(PP)分析中,只包括那些有可用数据的人,但与未参加随访调查的个体进行特征比较。另一项意向治疗(ITT)分析使用多个输入数据来弥补缺失数据。结果:共有71名受试者(46.7%)参与随访。在PP和ITT样本中证实,与CBT相比,以临床评价HT评估的症状减轻百分比的非劣效性。在治疗结束时,自我评价和临床评价的症状改善在随访期间持续存在。报告了自我评价和临床评价的反应率和缓解率。结论:本研究发现,HT治疗抑郁症的适应症不逊于CBT,即使是长期的。进一步的研究应该在更大的多中心样本中检验HT的疗效,并确定个体治疗成功的预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信